Xenetic Biosciences plc - Company Profile

BioCentury | Apr 21, 2014

Company News

Xenetic hematology news

...In 1Q14, U.K.-based Xenetic Biosciences plc became U.S.-based Xenetic Biosciences Inc. In January, Xenetic Biosciences plc delisted from LSE and...
...for anemia in chronic kidney disease (CKD). Last November, General Sales and Leasing Inc. and Xenetic Biosciences plc...

BioCentury | Feb 10, 2014

Company News

Xenetic Biosciences Inc, Baxter deal

...The partners amended a 2005 deal under which Xenetic (formerly Lipoxen plc ) granted Baxter exclusive...

BioCentury | Dec 9, 2013

Clinical News

PSA-Oxyntomodulin: Phase I started

...I trial to evaluate 3 dose levels of PSA-Oxyntomodulin in 12 healthy volunteers. Xenetic (formerly Lipoxen...
...product outside of Russia under a 2009 deal with Pharmsynthez (see BioCentury, Nov. 23, 2009). Xenetic Biosciences plc...

BioCentury | Dec 9, 2013

Clinical News

PulmoXen: Phase I started

...trial to evaluate 2,500 and 5,000 units of PulmoXen in 12 healthy volunteers. Xenetic (formerly Lipoxen...
...outside of Russia under a November 2009 deal with Pharmsynthez (see BioCentury, Nov. 23, 2009). Xenetic Biosciences plc...

BioCentury | Nov 18, 2013

Company News

General Sales and Leasing, Xenetic Biosciences deal

...use in sightseeing and pilot training. General Sales and Leasing Inc. (GSL) (OTCQB:GAIF), Scottsdale, Arizona Xenetic Biosciences plc...

BioCentury | Nov 4, 2013

Clinical News

ErepoXen: Phase II started

...in Russia, while Serum Institute has co-development rights in India. SynBio LLC , Moscow, Russia Xenetic Biosciences plc...

BioCentury | Oct 28, 2013

Company News

General Sales & Leasing Inc. (GSL), Xenetic Biosciences deal

...The companies declined to disclose details. General Sales & Leasing Inc. (GSL) (OTCQB:GAIF), Scottsdale, Ariz. Xenetic Biosciences plc...

BioCentury | Aug 12, 2013

Clinical News

ErepoXen: Phase II started

...in Russia, while Serum Institute has co-development rights in India. SynBio LLC , Moscow, Russia Xenetic Biosciences plc...

BioCentury | Jul 15, 2013

Company News

Xenetic management update

Xenetic Biosciences plc (LSE: XEN; OTCBB:XENEF), London, U.K. Business: Drug delivery Hired: Robert Gagnon as CFO of Xenetic's Xenetic Biosciences Inc. U.S. subsidiary, formerly EVP, CFO and treasurer of Clean Harbors Inc. WIR Staff...

BioCentury | May 20, 2013

Clinical News